Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $10,902 | 5 | 95.6% |
| Travel and Lodging | $486.59 | 1 | 4.3% |
| Food and Beverage | $19.44 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc. | $5,715 | 2 | $0 (2020) |
| PFIZER INC. | $5,006 | 3 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $537.00 | 1 | $0 (2018) |
| COMSORT, Inc | $150.00 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $5,715 | 2 | Bayer HealthCare Pharmaceuticals Inc. ($5,715) |
| 2018 | $687.00 | 2 | AstraZeneca Pharmaceuticals LP ($537.00) |
| 2017 | $5,006 | 3 | PFIZER INC. ($5,006) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2020 | Bayer HealthCare Pharmaceuticals Inc. | Non-Covered | Consulting Fee | Cash or cash equivalent | $2,857.50 | General |
| 12/11/2020 | Bayer HealthCare Pharmaceuticals Inc. | Non-Covered | Consulting Fee | Cash or cash equivalent | $2,857.50 | General |
| 12/11/2018 | COMSORT, Inc | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $150.00 | General |
| Category: ONCOLOGY | ||||||
| 05/16/2018 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Consulting Fee | Cash or cash equivalent | $537.00 | General |
| Category: Oncology | ||||||
| 07/10/2017 | PFIZER INC. | MYLOTARG (Drug) | Consulting Fee | Cash or cash equivalent | $4,500.00 | General |
| Category: ONCOLOGY | ||||||
| 03/13/2017 | PFIZER INC. | MYLOTARG (Biological) | Travel and Lodging | In-kind items and services | $486.59 | General |
| Category: ONCOLOGY | ||||||
| 03/13/2017 | PFIZER INC. | MYLOTARG (Biological) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: ONCOLOGY | ||||||
About Daniel Budman
Daniel Budman is a Hematology & Oncology healthcare provider based in Lake Success, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/06/2007. The National Provider Identifier (NPI) number assigned to this provider is 1376673764.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Daniel Budman has received a total of $11,408 in payments from pharmaceutical and medical device companies, with $5,715 received in 2020. These payments were reported across 7 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($10,902).
Practice Information
- Specialty Hematology & Oncology
- Location Lake Success, NY
- Active Since 03/06/2007
- Last Updated 07/08/2007
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1376673764
Products in Payments
- Non-Covered $5,715
- MYLOTARG (Drug) $4,500
- IMFINZI (Drug) $537.00
- MYLOTARG (Biological) $506.03
- KEYTRUDA (Biological) $150.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Lake Success
Veena John
Hematology & Oncology — Payments: $40,463
Jonathan Kolitz, Md, MD
Hematology & Oncology — Payments: $31,875
Steven Allen
Hematology & Oncology — Payments: $26,466
Thomas Bradley, Md, MD
Hematology & Oncology — Payments: $23,593
Ruthee-Lu Bayer, Md, MD
Hematology & Oncology — Payments: $7,053
Richard Stark, Md, MD
Hematology & Oncology — Payments: $5,941